Increasing, the Specificity of Polyclonal Antibodies to Human and Mouse β2-Microglobulin as an Alternative to the Use of Monoclonal Antibodies in Immunological Analysis

Highly specific reagents, i.e., proteins and antibodies to them, are the necessary components of systems for verifying the effectiveness of transgenic/knockout animal biomodels. In particular, the identification of   mouse and human β2-microglobulin in the protein fractions of organs and tissues of transgenic and β2m knockout mice of several HLA lines, which have been created in recent years at the Scientific Center of  Biomedical Technologies of the FMBA of Russia, is the most important stage of their certification. At  the first stage of our research,  E. coli  producing strains of recombinant mouse and human β2-microglobulin (mβ2mg and hβ2mg) were obtained, the proteins were isolated and purified. At the next stage of the work, affine sorbents with immobilized mβ2mg and hβ2mg were obtained. To increase the species specificity of the serum, “rabbit-anti-hβ2mg” were depleted against the recombinant protein mβ2mg, and, conversely, “rabbit-anti-mβ2mg” were depleted against the recombinant protein hβ2mg. Highly specific antibodies were purified from depleted sera using affinity sorbents. Using dot- and western-blotting methods оn the example of depleted and affinity-purified rabbit-anti-hβ2mg antibodies, a significant increase in  their specificity relative to hβ2mg was shown.

1. Karkischenko N.N., Ryabykh V.P., Karkischenko V.N., Koloskova E.M. Sozdanie gumanizirovannykh myshey dlya farmakotoksikologicheskikh issledovaniy (uspekhi, neudachi I perspektivy) [Creation of humanized mice for pharmacotoxicological research (successes, failures and prospects)]. Biomeditsina [ Journal Biomed]. 2014;1(3):4–22. (In Russian).

2. Karkischenko V.N., Petrova N.V., Savchenko E.S., Ogneva N.S., Koloskova E.M., Maksimenko S.V., Manuvera V.A., Bobrovsky P.A., Lazarev V.N. Sozdanie polnih gibritnih DNKkonstrukcij s genom cheloveka HLA-A*02:01:01:01 [Chimeric Construct Engineering with Human Variant HLA-A*02:01:01:01]. Biomeditsina [ Journal Biomed]. 2021;17(1):10–23. (In Russian).

3. Karkischenko N.N., Lazarev V.N., Manuvera V.A., Bobrovsky P.A., Petrova N.V., Koloskova E.M., Glotova E.S. Principy sozdaniya genno-inzhenernoj konstrukcii dlya polucheniya gumanizirovannyh transgennyh myshej, nesushchih gen HLA-S*07:02:01:01, kak proobraz innovacionnyh transgenno-nokautnyh biomodelej [Principles of Creation of a Genetic Engineering Construction for Obtaining Humanized Transgenic Mice with HLA-C*07:02:01:01, as a Promote of Innovative ransgenic and Knockout Biomodels]. Biomeditsina [Journal Biomed]. 2024;20(1):8–20. (In Russian). doi: 10.33647/2074-5982-20-1-8-20.

4. Petrova N.V., Skripkina M.M. Osobennosti organizacii soderzhaniya i vyvedeniya transgennyh linij myshej v NCBMT FMBA Rossii [Maintenance and Breeding of Transgenic Mouse Strains at the Scientific Center of Biomedical Technologies of the FMBA of Russia]. Biomeditsina [ Journal Biomed]. 2021;17(3E):70–75. DOI: 10.33647/2713-0428-17-3E-70-75.

5. Savchenko E.S., Ogneva N.S., Karkischenko N.N. Embriologicheskie aspekty sozdaniya novoj gumanizirovannoj transgennoj linii myshej s integrirovannym genom cheloveka HLA-A*02:01:01:01 [Embryological aspects of creation a new humanized transgenic mice with integrated human HLA-A*02:01:01:01 gene]. Biomedicina [Journal Biomed]. 2022;18(4):10–23. (In Russian). DOI: 10.33647/2074-5982-18-4-10-23.

6. Faber E., Tshilwane S.I., Van Kleef M., Pretorius A. The impact of Escherichia coli contamination products present in recombinant African horse sickness virus serotype 4 proteins on the innate and humoral immune responses, Molecular Immunology. 2022:152:1–13. DOI: 10.1016/j.molimm.2022.09.013.

7. Loralyn A.B., Rusung T. Xenogeneic β2-Microglobulin Substitution Affects Functional Binding of MHC Class I Molecules by CD8+ T Cells. J. Immunol. 2007;179(6):3588–3595. DOI: 10.4049/jimmunol.179.6.3588.

8. Nakane P.K., Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 1974;22(12):1084–1091. DOI: 10.1177/22.12.1084.

9. Vaitukaitis J.L. Production of antisera with small doses of immunogen: Multiple intradermal injections. Methodsin Enzymology. 198;73:46–52.

10. Williams R.C. Jr., Malone C.C. Antigenic epitopes on beta 2-microglobulin reacting with monoclonal antibodies. J. Lab. Clin. Med. 1993;121(6):805–820.